| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.01 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.094 | 0.02 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.02 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |